{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:01:57Z","timestamp":1793124117321,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.ygyno.2008.02.006","type":"journal-article","created":{"date-parts":[[2008,4,21]],"date-time":"2008-04-21T20:11:59Z","timestamp":1208808719000},"page":"370-376","source":"Crossref","is-referenced-by-count":388,"title":["Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers"],"prefix":"10.1016","volume":"109","author":[{"given":"John K.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob Y.","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Osann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Kapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2008.02.006_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2008.02.006_bib2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0090-8258(89)90043-7","article-title":"Clear cell carcinoma of the ovary: a study of 59 cases","volume":"35","author":"Crozier","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.02.006_bib3","first-page":"263","article-title":"Prognostic factors in patients with stage I epithelial ovarian cancer","volume":"75","author":"Dembo","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2008.02.006_bib4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/gyno.1999.5445","article-title":"Survival probability in ovarian clear cell adenocarcinoma","volume":"74","author":"Kennedy","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.02.006_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00000478-200402000-00001","article-title":"Clinicopathologic analysis of early-stage sporadic ovarian carcinoma","volume":"28","author":"Leitao","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2008.02.006_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0090-8258(89)90852-4","article-title":"Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma","volume":"32","author":"Jenison","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.02.006_bib7","first-page":"143","article-title":"Platinum-based chemotherapy of high-risk stage I epithelial ovarian cancer following comprehensive surgical staging","volume":"82","author":"Rubin","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2008.02.006_bib8","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1002\/1097-0142(20000601)88:11<2584::AID-CNCR22>3.3.CO;2-X","article-title":"Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy","volume":"88","author":"Sugiyama","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.02.006_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2005.12.038","article-title":"Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience","volume":"102","author":"Pectasides","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.02.006_bib10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1006\/gyno.1996.0065","article-title":"Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease","volume":"60","author":"Goff","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.02.006_bib11","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/(SICI)1097-0142(19961115)78:10<2157::AID-CNCR17>3.0.CO;2-Y","article-title":"Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy","volume":"78","author":"Recio","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2008.02.006_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0029-7844(02)02040-9","article-title":"Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary","volume":"100","author":"Itamochi","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2008.02.006_bib13","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","article-title":"Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study","volume":"25","author":"Winter","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2008.02.006_bib14","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1200\/JCO.2007.11.0114","article-title":"PIEPOC: a new prognostic index for advanced epithelial ovarian cancer \u2014 Japan Multinational Trial Organization OC01-01","volume":"25","author":"Teramukai","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2008.02.006_bib15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0090-8258(89)90637-9","article-title":"Ovarian clear cell adenocarcinoma","volume":"32","author":"Kennedy","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.02.006_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00005650-200208001-00007","article-title":"Studying radiation therapy using SEER-Medicare-linked data","volume":"40","author":"Virnig","year":"2002","journal-title":"Med Care"},{"key":"10.1016\/j.ygyno.2008.02.006_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1006\/gyno.2000.5840","article-title":"Comparative study of ovarian cancer histopathology by registry pathologists and referral pathologists: a study by the Gilda Radner Familial Ovarian Cancer Registry","volume":"78","author":"Piver","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.02.006_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0002-9378(91)90628-5","article-title":"The diagnosis of ovarian cancer by pathologists: how often do diagnoses by contributing pathologists agree with a panel of gynecologic pathologists?","volume":"164","author":"Tyler","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2008.02.006_bib19","article-title":"Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study","author":"Takano","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2008.02.006_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1525-1438.2006.00289.x","article-title":"Paclitaxel-platinum combination chemotherapy for advanced or recurrent ovarian clear cell adenocarcinoma: a multicenter trial","volume":"16","author":"Utsunomiya","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2008.02.006_bib21","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.ygyno.2005.03.009","article-title":"Irinotecan hydrochloride (CPT-11) and mitomycin C as the first line chemotherapy for ovarian clear cell adenocarcinoma","volume":"97","author":"Nishino","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.02.006_bib22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s10147-007-0670-1","article-title":"Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis","volume":"12","author":"Takano","year":"2007","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ygyno.2008.02.006_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ygyno.2007.03.041","article-title":"Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma","volume":"106","author":"Lee","year":"2007","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808001200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808001200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T17:27:18Z","timestamp":1546104438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825808001200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0090825808001200"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.02.006","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}